highperformr logo

Autolus Therapeutics's Overview

Total employees694
HeadquartersLondon
Founded2014

Autolus Therapeutics plc is a clinical-stage biopharmaceutical company developing next-generation, programmed T cell therapies for the treatment of cancer. The company's pipeline includes innovative CAR-T cell therapies designed to recognize and kill cancer cells, with a focus on hematological malignancies and solid tumors. Autolus aims to deliver transformative treatments by engineering T cells with enhanced precision, safety, and efficacy.

Where is Autolus Therapeutics's Headquarters?

HQ Function

Serves as the central hub for corporate strategy, research leadership, clinical development oversight, financial operations, and administrative functions.

Notable Features:

Located within The MediaWorks, a modern campus designed to foster collaboration and innovation, part of London's growing White City Innovation District.

Work Culture:

A dynamic, science-driven environment focused on innovation, collaboration, and a commitment to advancing patient care. Employees are typically engaged in cutting-edge research and development with a strong sense of purpose.

HQ Significance:

The headquarters is pivotal for orchestrating Autolus's global operations, R&D efforts, and strategic partnerships, driving the development of its novel T cell therapies.

Values Reflected in HQ: The choice of a modern, innovative campus reflects Autolus's commitment to cutting-edge science, collaboration, and forward-thinking approaches to cancer therapy.

Location:

Autolus Therapeutics primarily operates from its key sites in the United Kingdom (London and Stevenage) and the United States (Rockville, MD). These locations support global research and development, clinical trial management across multiple countries, manufacturing of its cell therapies, and strategic corporate functions. While physical offices are concentrated, their clinical trials and collaborations extend internationally, giving them a functional global reach in the biopharmaceutical landscape.

Street Address:

The MediaWorks, 191 Wood Lane

City:

London

State/Province:

White City

Country:

United Kingdom

Autolus Therapeutics's Global Presence

Stevenage, Hertfordshire, United Kingdom

Address: The Nucleus, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2FX, UK

Located in the Stevenage Bioscience Catalyst campus, a key UK hub for cell and gene therapy, providing access to specialized infrastructure and talent for advanced therapy manufacturing.

Rockville, Maryland, USA

Address: 9800 Medical Center Drive, Suite C-120, Rockville, MD 20850, USA

Strategically positioned to access the US pharmaceutical market, engage with US regulatory authorities, and collaborate with leading US clinical research institutions.

Buying Intent Signals for Autolus Therapeutics

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Autolus Therapeutics

As of April 2025, Autolus Therapeutics' leadership includes:

Dr. Christian Itin - Chief Executive Officer
Dr. Lucinda Crabtree - Chief Financial Officer
Dr. Martin Pule - Founder and Chief Scientific Officer
Dr. Muhammad Al-Hajj - Chief Operating Officer
Dr. Edgar Braendle - Chief Development Officer
Christopher Vann - Chief Commercial Officer
Robert Dolski - General Counsel and Corporate Secretary

Investors of Autolus Therapeutics

Autolus Therapeutics has been backed by several prominent investors over the years, including:

Syncona Limited
Blackstone Life Sciences
Redmile Group, LLC
Wellington Management Group LLP
Capital Group
Woodford Investment Management (historical, significant early investor)
Arix Bioscience plc

Executive New Hires/Exits in the Last 12 Months

Hire2
Exits1

Autolus Therapeutics has strengthened its executive team over the past year with key appointments in finance and commercial operations, including a new Chief Financial Officer and a new Chief Commercial Officer, positioning the company for its next phase of growth and potential commercialization.

Departures

Dr. Andrew J. Oakley, Dr. Andrew J. Oakley departed as Chief Financial Officer, with Dr. Lucinda Crabtree assuming the role.

New Appointments:

Christopher Vann, Christopher Vann appointed as new Chief Commercial Officer to build out commercial capabilities.
Dr. Lucinda Crabtree, Dr. Lucinda Crabtree appointed as new Chief Financial Officer, taking over financial leadership.

Technology (Tech Stack) used by Autolus Therapeutics

Discover the tools Autolus Therapeutics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Autolus Therapeutics Email Formats and Examples

Autolus Therapeutics plc likely uses common corporate email formats. The most probable patterns are [first_initial][lastname]@autolus.com or [first].[lastname]@autolus.com. For example, for an employee named Jane Doe, the email could be jdoe@autolus.com or jane.doe@autolus.com.

[first_initial][lastname]@autolus.com or [first].[lastname]@autolus.com

Format

j.doe@autolus.com

Example

80%

Success rate

News and media

Autolus Therapeutics plcMay 22, 2024

Autolus Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Autolus announced its financial results for Q1 2024, highlighting progress with its obe-cel BLA submission to the FDA and ongoing clinical development programs....more

Autolus Therapeutics plcApril 29, 2024

Autolus Therapeutics Announces Submission of Biologics License Application (BLA) to U.S. Food and Drug Administration (FDA) for Obe-cel in Relapsed/Refractory (r/r) Adult B-Cell Acute Lymphoblastic Leukemia (ALL)

Autolus submitted its BLA for obecabtagene autoleucel (obe-cel) for adult patients with r/r B-ALL, a significant milestone for the company....more

Autolus Therapeutics plcMarch 4, 2024

Autolus Therapeutics Announces Appointment of Christopher Vann as Chief Commercial Officer

Autolus appointed Christopher Vann as CCO to lead its global commercial strategy and operations as it prepares for potential product commercialization....more

Autolus Therapeutics plcJanuary 29, 2024

Autolus Therapeutics to Present at Upcoming Investor Conferences in February

Autolus announced its participation in several key investor conferences to provide business updates and discuss its pipeline progress....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Autolus Therapeutics, are just a search away.